Cancer Research Revenue and Competitors
Estimated Revenue & Valuation
- Cancer Research's estimated annual revenue is currently $2.8M per year.
- Cancer Research's estimated revenue per employee is $155,000
Employee Data
- Cancer Research has 18 Employees.
- Cancer Research grew their employee count by -42% last year.
Cancer Research's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP, Bioengineering | Reveal Email/Phone |
2 | SVP, Discovery Research | Reveal Email/Phone |
3 | Associate Director, Immunobiology | Reveal Email/Phone |
4 | Director Business Development Operations | Reveal Email/Phone |
5 | CHIEF BUSINESS AND LEGAL OFFICER | Reveal Email/Phone |
6 | CHIEF FINANCIAL OFFICER | Reveal Email/Phone |
7 | DRUG DEVELOPMENT ADVISOR | Reveal Email/Phone |
8 | Research Associate III | Reveal Email/Phone |
Cancer Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $944.4M | 2776 | 5% | N/A | N/A |
What Is Cancer Research?
At Systems Oncology, we believe that innovating cancer drug discovery requires the exponential power of AI to uncover deeper mechanistic insights into cancer biology. Equipped with advanced cognitive computing technologies, we are able to aggregate and mine disparate types of biomedical datasets to reveal novel contextual vulnerabilities in cancer, and collaborate with leading universities to exploit those vulnerabilities with cutting-edge agents. We then invest in the most promising experimental agents to demonstrate their therapeutic potential. Finally, we partner with pharmaceutical companies to transform innovative new agents into the next breakthrough cancer therapies. Our multidisciplinary team includes world-class experts from fields ranging from mathematics and AI to systems biology and oncology, all guided by deep clinical development experience. The combined expertise and our revolutionary approach empower us to discover and develop the next generation of cancer therapies with unprecedented speed and precision.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cancer Research News
A single nanoparticle does two jobs: enhancing the effectiveness of chemotherapy and reinvigorating the immune system.
Cambridge research reveals 58 new mutational signatures, raising hopes of a cancer care revolution based around personalised treatment.
An "archaeological dig" of thousands of tumours in the UK has unearthed new patterns in cancer's DNA.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 18 | 50% | N/A |
#2 | $2.6M | 18 | N/A | N/A |
#3 | $4.5M | 18 | 20% | N/A |
#4 | $1.6M | 18 | -42% | N/A |
#5 | $2.9M | 18 | -5% | N/A |